ABIONYX Pharma SA (LON: 0RAG)
London
· Delayed Price · Currency is GBP · Price in EUR 1.320
0.00 (0.00%)
At close: Jan 20, 2025
ABIONYX Pharma Revenue
ABIONYX Pharma had revenue of 2.34M EUR in the half year ending June 30, 2024, a decrease of -10.87%. This brings the company's revenue in the last twelve months to 4.86M, up 2.23% year-over-year. In the year 2023, ABIONYX Pharma had annual revenue of 4.64M, down -11.65%.
Revenue (ttm)
4.86M EUR
Revenue Growth
+2.23%
P/S Ratio
n/a
Revenue / Employee
79.61K EUR
Employees
61
Market Cap
37.19M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| Shell | 221.41B |
| HSBC Holdings | 43.25B |
| Unilever | 51.12B |
| Rio Tinto Group | 42.87B |
| RELX PLC | 9.30B |
| BP p.l.c. | 144.69B |
| British American Tobacco p.l.c. | 26.18B |